221 related articles for article (PubMed ID: 18396641)
1. [Expression and clinical significance of CD44v6 and sCD44v6 in gastric carcinoma].
Zhou DH; Ma ZM; Chen Y
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):833-7. PubMed ID: 18396641
[TBL] [Abstract][Full Text] [Related]
2. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma.
Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer.
Yamane N; Tsujitani S; Makino M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):232-8. PubMed ID: 10202279
[TBL] [Abstract][Full Text] [Related]
4. [Expression of MUC1, CD44v6, nm23 in gastric carcinomas and regional lymph node tissues and their association with invasion, metastasis, and prognosis of the tumor].
Li Y; Zhang JH; Kuang G; Yang JQ; Zhao Q; Wang XL; Jiao ZK; Zhang ZD; Wang LL
Ai Zheng; 2003 Sep; 22(9):985-9. PubMed ID: 12969535
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between sCD44v6 expression and TCM differentiation type of gastric carcinoma patients and influence of weitai capsule on the expression].
Chen X; Ouyang XN; Dai XH; Chen MH; Lin QC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jan; 25(1):12-5. PubMed ID: 15719741
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prognostic value and functional roles of CD44v6 in gastric cancer.
Xie JW; Chen PC; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Lin Y; Huang CM
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1809-17. PubMed ID: 25809905
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma].
Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J
Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma.
Castellà EM; Ariza A; Pellicer I; Fernández-Vasalo A; Ojanguren I
J Clin Pathol; 1998 Feb; 51(2):134-7. PubMed ID: 9602687
[TBL] [Abstract][Full Text] [Related]
11. [GRP78 expression in gastric cancer and its clinical significance].
Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
[TBL] [Abstract][Full Text] [Related]
12. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
13. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma.
Yin C; Li D; Sun Z; Zhang T; Xu Y; Wang Z; Xu H
Med Oncol; 2012 Jun; 29(2):864-70. PubMed ID: 21298368
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of RhoC, CD44v6 and ICAM-1 in human gastric cancer and its clinicopathological significance].
Zhao ZQ; Yu PW; Zhao YL; Shi Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jul; 8(4):352-5. PubMed ID: 16167261
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis.
Yamaguchi A; Goi T; Yu J; Hirono Y; Ishida M; Iida A; Kimura T; Takeuchi K; Katayama K; Hirose K
J Surg Oncol; 2002 Apr; 79(4):230-5. PubMed ID: 11920780
[TBL] [Abstract][Full Text] [Related]
18. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6.
Weg-Remers S; Hildebrandt U; Feifel G; Moser C; Zeitz M; Stallmach A
Am J Gastroenterol; 1998 May; 93(5):790-4. PubMed ID: 9625129
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]